Meiling Deng

423 total citations
31 papers, 258 citations indexed

About

Meiling Deng is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Meiling Deng has authored 31 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Meiling Deng's work include Head and Neck Cancer Studies (7 papers), Glioma Diagnosis and Treatment (6 papers) and Brain Metastases and Treatment (6 papers). Meiling Deng is often cited by papers focused on Head and Neck Cancer Studies (7 papers), Glioma Diagnosis and Treatment (6 papers) and Brain Metastases and Treatment (6 papers). Meiling Deng collaborates with scholars based in China, United States and Thailand. Meiling Deng's co-authors include Wangyuan Zou, Jing Wu, Zengli Zhang, Shaoxiong Wu, Jian Wang, Qulian Guo, Mian Xi, Yujia Zhu, Yonghong Hu and Yingqi Weng and has published in prestigious journals such as Scientific Reports, Pain and Neuroscience.

In The Last Decade

Meiling Deng

29 papers receiving 256 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Meiling Deng 85 80 68 61 57 31 258
Claudia Gedlicka 157 1.8× 91 1.1× 244 3.6× 48 0.8× 84 1.5× 16 383
Michael Christensen 66 0.8× 155 1.9× 52 0.8× 52 0.9× 83 1.5× 19 296
Jakob Admard 138 1.6× 23 0.3× 31 0.5× 60 1.0× 12 0.2× 22 272
Liujun Jiang 192 2.3× 47 0.6× 47 0.7× 91 1.5× 47 0.8× 24 354
Kelei Gao 80 0.9× 34 0.4× 53 0.8× 36 0.6× 76 1.3× 26 292
Tetsuya Yoshizumi 127 1.5× 23 0.3× 64 0.9× 78 1.3× 98 1.7× 25 297
Peter Groth 126 1.5× 33 0.4× 93 1.4× 28 0.5× 113 2.0× 18 479
Soheil Zorofchian 114 1.3× 97 1.2× 52 0.8× 79 1.3× 10 0.2× 10 336
Leonidas Chelis 121 1.4× 111 1.4× 115 1.7× 104 1.7× 41 0.7× 22 396
Jia Geng 86 1.0× 71 0.9× 35 0.5× 29 0.5× 30 0.5× 13 317

Countries citing papers authored by Meiling Deng

Since Specialization
Citations

This map shows the geographic impact of Meiling Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiling Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiling Deng more than expected).

Fields of papers citing papers by Meiling Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meiling Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiling Deng. The network helps show where Meiling Deng may publish in the future.

Co-authorship network of co-authors of Meiling Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Meiling Deng. A scholar is included among the top collaborators of Meiling Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meiling Deng. Meiling Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Wenwen, et al.. (2024). The impact of massive EV charging on distribution lines. Journal of Physics Conference Series. 2703(1). 12065–12065. 4 indexed citations
3.
Du, Xiaojing, et al.. (2024). Successful replacement for recurrent nasopharyngeal carcinoma with cholecystitis induced by PD-1 antibody: a case report. Immunotherapy. 16(14-15). 949–953. 1 indexed citations
4.
Zhang, Jie, et al.. (2024). Circulating chemerin and interleukin-6 in children with obesity: possible metabolic risk predictors. Translational Pediatrics. 13(10). 1760–1766. 1 indexed citations
5.
Wang, Zhenning, Hao Duan, Zhenqiang He, et al.. (2023). Survival Benefits of Radiotherapy and Surgery in Lung Cancer Brain Metastases with Poor Prognosis Factors. Current Oncology. 30(2). 2227–2236. 1 indexed citations
6.
Yang, Qunying, Zhiqing Wei, Tingting Chen, et al.. (2023). Treatment Outcome of Response-Based Radiation Therapy in Children and Adolescents With Central Nervous System Nongerminomatous Germ Cell Tumors: Results of a Prospective Study. International Journal of Radiation Oncology*Biology*Physics. 119(3). 858–868. 1 indexed citations
7.
Pan, Houjun, Meiling Deng, Bin Zhang, Tiantian Fang, & Yuguo Liu. (2023). Transcriptome analysis of Tetrahymena thermophila response to exposure with dihydroartemisinin. Heliyon. 9(3). e14069–e14069. 2 indexed citations
8.
Yang, Qunying, Zhiqing Wei, Tingting Chen, et al.. (2023). Treatment outcomes for response-based radiotherapy in children and adolescents with central nervous system germinoma: a prospective study. Journal of Neuro-Oncology. 164(3). 643–653.
9.
Deng, Meiling, Zengli Zhang, Liang Xia, et al.. (2022). LncRNA MRAK159688 facilitates morphine tolerance by promoting REST-mediated inhibition of mu opioid receptor in rats. Neuropharmacology. 206. 108938–108938. 11 indexed citations
10.
Chen, Yinsheng, et al.. (2022). Longest survival with primary intracranial malignant melanoma: A case report and literature review. World Journal of Clinical Cases. 10(30). 11162–11171. 1 indexed citations
11.
Zhang, Honghong, Xiaojing Du, Meiling Deng, et al.. (2022). Apatinib for recurrent/progressive glioblastoma multiforme: A salvage option. Frontiers in Pharmacology. 13. 969565–969565. 3 indexed citations
12.
Wu, Jing, et al.. (2022). CircRalgapa1 facilitates morphine tolerance via miR-873a-5p/A20 axis in mice. Neuropharmacology. 224. 109353–109353. 3 indexed citations
13.
Chen, Baoqing, Meiling Deng, Yang Chen, et al.. (2021). High incidence of esophageal fistula on patients with clinical T4b esophageal squamous cell carcinoma who received chemoradiotherapy: A retrospective analysis. Radiotherapy and Oncology. 158. 191–199. 22 indexed citations
14.
Cai, Xiuyu, Meiling Deng, Zhiyong Li, et al.. (2020). Unique genomic features and prognostic value of COSMIC mutational signature 4 in lung adenocarcinoma and lung squamous cell carcinoma. Annals of Translational Medicine. 8(18). 1176–1176. 8 indexed citations
15.
Deng, Meiling, et al.. (2018). Characteristics and Treatment of Brain Metastases from Esophageal Squamous Cell Carcinoma. Journal of Cancer. 9(5). 901–905. 8 indexed citations
16.
Feng, Huixia, Weiwei Xiao, Qiaoxuan Wang, et al.. (2018). Cycle number of neoadjuvant chemotherapy might influence survival of patients with T1-4N2-3M0 nasopharyngeal carcinoma. Chinese Journal of Cancer Research. 30(1). 51–60. 22 indexed citations
17.
18.
Lan, Mei, Chunyan Chen, Ying Huang, et al.. (2017). Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients with cervical nodal necrosis. Scientific Reports. 7(1). 42624–42624. 14 indexed citations
19.
Han, Fei, Weiwei Xiao, Hanyu Wang, et al.. (2012). Influence of intensity-modulated radiotherapy on tumor regression in nasopharyngeal carcinoma. Zhonghua fangshe yixue yu fanghu zazhi. 32(2). 204–206. 4 indexed citations
20.
Deng, Meiling, Shaoxiong Wu, Shaomin Huang, et al.. (2010). A comparative study of 11C-MET PET with MRI for target volume delineation in postoperative radiotherapy for brain high grade glioma. Zhonghua fangshe zhongliuxue zazhi. 19(5). 415–419. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia Gedlicka Breakdown of academic impact, for papers by Michael Christensen Breakdown of academic impact, for papers by Jakob Admard Breakdown of academic impact, for papers by Liujun Jiang Breakdown of academic impact, for papers by Kelei Gao Breakdown of academic impact, for papers by Tetsuya Yoshizumi Breakdown of academic impact, for papers by Peter Groth Breakdown of academic impact, for papers by Soheil Zorofchian Breakdown of academic impact, for papers by Leonidas Chelis Breakdown of academic impact, for papers by Jia Geng
Rankless by CCL
2026